Lori Jean Van Orden

Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse

Sharon L. Smith, Eloise J. Kuijer, Filomene G. Morrison, 2024, Neuropharmacology.